603
Views
9
CrossRef citations to date
0
Altmetric
Review

The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphoma

, , , , , , & show all
Pages 12-25 | Received 17 Oct 2013, Accepted 07 Feb 2014, Published online: 24 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ombretta Annibali, Francesca Chiodi, Natalia Cenfra, Chiara Sarlo, Simona Mega, Ilaria Cavallari, Angela Rago, Simona Tomassini, Sergio Mecarocci, Giuseppe Cimino & Giuseppe Avvisati. (2016) ‘Real Life’ experience in a ‘difficult to treat’ patient population of non-Hodgkin lymphomas using the R-COMP regimen. Leukemia & Lymphoma 57:12, pages 2919-2922.
Read now

Articles from other publishers (8)

Anastasia Stella Perpinia, Nikolaos Kadoglou, Maria Vardaka, Georgios Gkortzolidis, Apostolos Karavidas, Theodoros Marinakis, Chrysostomi Papachrysostomou, Panagiotis Makaronis, Charikleia Vlachou, Marina Mantzourani, Dimitrios Farmakis & Konstantinos Konstantopoulos. (2022) Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies. Pharmaceuticals 15:8, pages 1007.
Crossref
Sabrina Mariani, Sabrina Pelliccia, Maria Paola Bianchi, Monica Piedimonte, Martina Bongiovanni, Marco Testa, Arianna Di Napoli & Agostino Tafuri. (2021) Arrhythmias and Cardiogenic Shock: A Rare Disease Presentation of Diffuse Large B-Cell Lymphoma with Cardiac Involvement. Hemato 2:2, pages 353-357.
Crossref
Luigi Rigacci, Ombretta Annibali, Sofya Kovalchuk, Elisabetta Bonifacio, Francesca Pregnolato, Francesco Angrilli, Umberto Vitolo, Samantha Pozzi, Serena Broggi, Stefano Luminari, Francesco Merli, Michele Spina, Silvia Bolis, Gloria Margiotta‐Casaluci, Rosario Scalzulli, Christina Cox, Angela Maria Mamusa, Armando Santoro, Pier Luigi Zinzani, Samantha Ferrari, Guido Gini, Maria Luigia Vigliotti, Antonino Mulè & Leonardo Flenghi. (2020) Nonpeghylated liposomal doxorubicin combination regimen ( R‐COMP ) for the treatment of lymphoma patients with advanced age or cardiac comorbidity . Hematological Oncology 38:4, pages 478-486.
Crossref
Andrew J. Cowan, Damian J. Green, Mehdi Karami, Pamela S. Becker, Sherilyn Tuazon, David G. Coffey, Teresa S. Hyun, Edward N. Libby, Ajay K. Gopal & Leona A. Holmberg. (2020) KRD-PACE Mobilization for Multiple Myeloma Patients With Significant Residual Disease Before Autologous Stem-Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 20:9, pages 602-609.
Crossref
Murali Kesavan, Toby A. Eyre & Graham P. Collins. (2019) Front-Line Treatment of High Grade B Cell Non-Hodgkin Lymphoma. Current Hematologic Malignancy Reports 14:4, pages 207-218.
Crossref
Stefania Gobba, Alden A. Moccia, Wiebke Gulden-Sala, Annarita Conconi, Stefan Diem, Luciano Cascione, Gloria Iacoboni, Gloria Margiotta-Casaluci, Kathrin Aprile von Hohenstaufen, Anastasios Stathis, Felicitas Hitz, Graziella Pinotti, Gianluca Gaidano & Emanuele Zucca. (2018) Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with “standard” immunochemotherapy: A large retrospective study from 4 institutions. Hematological Oncology 36:1, pages 84-92.
Crossref
Emanuele Cencini, Alberto Fabbri, Susanna Guerrini, Maria Antonietta Mazzei, Vania Rossi & Monica Bocchia. (2016) Long-term remission in a case of plasmablastic lymphoma treated with COMP (cyclophosphamide, liposomal doxorubicin, vincristine, prednisone) and bortezomib. European Journal of Haematology 96:6, pages 650-654.
Crossref
Alberto Fabbri, Emanuele Cencini & Monica Bocchia. (2015) Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma. Cancer 121:20, pages 3746-3747.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.